KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,153,347 | -13.9% | 1,222,955 | -0.1% | 0.01% | 0.0% |
| Q2 2023 | $12,955,177 | -11.1% | 1,224,497 | +2.8% | 0.01% | -14.3% |
| Q1 2023 | $14,574,195 | +10.2% | 1,191,676 | +11.9% | 0.01% | 0.0% |
| Q4 2022 | $13,219,876 | +52.5% | 1,065,260 | +67.8% | 0.01% | +40.0% |
| Q3 2022 | $8,670,000 | -24.6% | 634,665 | +1.2% | 0.01% | -16.7% |
| Q2 2022 | $11,496,000 | +14.2% | 627,123 | +0.2% | 0.01% | +50.0% |
| Q1 2022 | $10,064,000 | -26.3% | 625,894 | -35.8% | 0.00% | -20.0% |
| Q4 2021 | $13,649,000 | -25.5% | 974,922 | -0.4% | 0.01% | -28.6% |
| Q3 2021 | $18,326,000 | -10.4% | 978,455 | -0.2% | 0.01% | -12.5% |
| Q2 2021 | $20,451,000 | -2.5% | 980,878 | +32.2% | 0.01% | -11.1% |
| Q1 2021 | $20,970,000 | +28.0% | 741,764 | +47.9% | 0.01% | +28.6% |
| Q4 2020 | $16,383,000 | +453.7% | 501,620 | -31.3% | 0.01% | +250.0% |
| Q1 2016 | $2,959,000 | -63.7% | 730,500 | -24.7% | 0.00% | -50.0% |
| Q4 2015 | $8,149,000 | – | 970,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |